Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Remote Patient Monitoring Market Snapshot
Chapter 4. Global Remote Patient Monitoring Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Global Remote Patient Monitoring Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on REMOTE PATIENT MONITORING MARKET Industry Trends
Chapter 5. Remote Patient Monitoring Market Segmentation 1: By Component, Estimates & Trend Analysis
5.1. Market Share by Component, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Component:
5.2.1. Devices
5.2.1.1. Function
5.2.1.1.1. Cardiac monitoring devices
5.2.1.1.2. Neurological monitoring devices
5.2.1.1.3. Respiratory monitoring devices
5.2.1.1.4. Blood glucose monitoring devices
5.2.1.1.5. Fetal & neonatal monitoring devices
5.2.1.1.6. Weight monitoring devices
5.2.1.1.7. Multiparameter monitoring devices
5.2.1.1.8. Pulse oximeter devices
5.2.1.1.9. Thermometers
5.2.1.1.10. Other monitoring devices
5.2.1.2. Type
5.2.1.2.1. Wearable devices
5.2.1.2.2. Implantable devices
5.2.1.2.3. Handheld & portable devices
5.2.1.2.4. Other devices
5.2.2. Software
5.2.2.1. Deployment Model
5.2.2.1.1. On-premise models
5.2.2.1.2. Cloud-based models
5.2.2.2. Transmission Type
5.2.2.2.1. Synchronous transmission
5.2.2.2.2. Asynchronous transmission
5.2.3. Services
5.2.3.1. Telemedicine platforms and integrated RPM service models
Chapter 6. Remote Patient Monitoring Market Segmentation 2: By Indication, Estimates & Trend Analysis
6.1. Market Share by Indication, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Indication:
6.2.1. Oncology
6.2.2. Cardiology
6.2.3. Neurology
6.2.4. Diabetes
6.2.5. Sleep disorders
6.2.6. Respiratory diseases (e.g., COPD, asthma)
6.2.7. Wellness improvement (weight management, personal health apps)
6.2.8. Mental health
6.2.9. Other indications
Chapter 7. Remote Patient Monitoring Market Segmentation 3: By End-Use, Estimates & Trend Analysis
7.1. Market Share by End-Use, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-Use:
7.2.1. Hospitals
7.2.2. Ambulatory Surgery Centers (ASCs) / Ambulatory Care Centers (ACCs) / Outpatient settings
7.2.3. Long-term care & assisted living facilities
7.2.4. Home healthcare
7.2.5. Other healthcare providers
7.2.6. Other End Users
7.2.6.1. Healthcare payers (insurance, managed care)
7.2.6.2. Patients (self-monitoring, consumer use)
7.2.6.3. Pharmaceutical & bioComponent companies
7.2.6.4. MedTech companies
7.2.6.5. Other end users
Chapter 8. Remote Patient Monitoring Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Remote Patient Monitoring Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021- 2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021- 2034
8.2.3. North America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021- 2034
8.2.4. North America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021- 2034
8.3. Europe
8.3.1. Europe Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021- 2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021- 2034
8.3.3. Europe Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021- 2034
8.3.4. Europe Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021- 2034
8.4. Asia Pacific
8.4.1. Asia Pacific Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021- 2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021- 2034
8.4.3. Asia Pacific Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts By Indication, 2021- 2034
8.4.4. Asia Pacific Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021- 2034
8.5. Latin America
8.5.1. Latin America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021- 2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021- 2034
8.5.3. Latin America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021- 2034
8.5.4. Latin America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021- 2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by country, 2021- 2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021- 2034
8.6.3. Middle East & Africa Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021- 2034
8.6.4. Middle East & Africa Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021- 2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Alten Calsoft Labs (A Subsidiary Of Alten Group)
9.2.3. American Telecare; Roche;
9.2.4. Bio-Beat Technologies
9.2.5. Biotronik;
9.2.6. Bosch;
9.2.7. Boston Scientific Corporation
9.2.8. Cerner Corporation
9.2.9. Covidien Plc.,
9.2.10. Dexcom, Inc.
9.2.11. GE Healthcare
9.2.12. Health Anywhere Inc.;
9.2.13. Honeywell;
9.2.14. Intel;
9.2.15. Irhythm Technologies
9.2.16. Johnson & Johnson;
9.2.17. Medtronic
9.2.18. Omron Healthcare Inc.
9.2.19. Philips Healthcare;
9.2.20. Preventice Solutions
9.2.21. Resideo Life Care Solutions
9.2.22. Siemens Healthineers Ag
9.2.23. Teledoc Health Inc.
9.2.24. Vitalconnect
9.2.25. Vivalnk Inc
9.2.26. Vivify Health, Inc.
9.2.27. Welch Allyn (A Subsidiary Of Hill Rom Services, Inc.
